Literature DB >> 26551634

Bone Marrow Harvesting of Allogeneic Donors in an Outpatient Setting: A Single-Center Experience.

Katharina Lisenko1, Peter Stadtherr1, Thomas Bruckner2, Petra Pavel3, Christoph E Heilig1, Anita Schmitt1, Joe Puthenparambil1, Juliane Brandt1, Anthony D Ho1, Peter Dreger1, Mathias Witzens-Harig1, Patrick Wuchter4.   

Abstract

The aim of this retrospective study was to assess the safety and efficacy of bone marrow (BM) harvesting of allogeneic donors in an outpatient setting. Data of 226 related and unrelated donors who underwent BM harvest under general anesthesia at our institution from 2002 to 2014 were analyzed. Sixteen patients were a priori planned for admission for social reasons and 210 patients underwent BM harvesting with the intention to perform this procedure on an outpatient basis. To identify factors that predispose for hospital admission, we retrospectively analyzed donor characteristics and collection parameters. Outpatient treatment was performed in 178 of 210 donors (85%), whereas 32 donors (15%) required admission for clinical reasons (mainly clinically relevant anemia and circulatory problems). These individuals were not significantly different in sex distribution, age, donor's body weight, and the proportion of related donors from those who were not admitted. However, we found a significantly higher collection volume per kilogram donor's body weight in inpatients compared with volume for outpatients (16 versus 13 mL/kg body weight, P < .001). Severe adverse events or deaths occurred neither in the inpatient nor in the outpatient setting. Our study demonstrated that BM harvest in an outpatient setting is safe and feasible for the majority of allogeneic donors. A high volume of BM represented a major risk factor for inpatient admission.
Copyright © 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic stem cell transplantation; Bone marrow donation; Outpatient setting

Mesh:

Year:  2015        PMID: 26551634     DOI: 10.1016/j.bbmt.2015.10.025

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  3 in total

1.  Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).

Authors:  Emerson C Perin; Michael P Murphy; Keith L March; Roberto Bolli; John Loughran; Phillip C Yang; Nicholas J Leeper; Ronald L Dalman; Jason Alexander; Timothy D Henry; Jay H Traverse; Carl J Pepine; R David Anderson; Scott Berceli; James T Willerson; Raja Muthupillai; Amir Gahremanpour; Ganesh Raveendran; Omaida Velasquez; Joshua M Hare; Ivonne Hernandez Schulman; Vijaykumar S Kasi; William R Hiatt; Bharath Ambale-Venkatesh; João A Lima; Doris A Taylor; Micheline Resende; Adrian P Gee; April G Durett; Jeanette Bloom; Sara Richman; Patricia G'Sell; Shari Williams; Fouzia Khan; Elsie Gyang Ross; Michelle R Santoso; JoAnne Goldman; Dana Leach; Eileen Handberg; Benjamin Cheong; Nichole Piece; Darcy DiFede; Barb Bruhn-Ding; Emily Caldwell; Judy Bettencourt; Dejian Lai; Linda Piller; Lara Simpson; Michelle Cohen; Shelly L Sayre; Rachel W Vojvodic; Lem Moyé; Ray F Ebert; Robert D Simari; Alan T Hirsch
Journal:  Circulation       Date:  2017-02-16       Impact factor: 29.690

2.  Ascorbic Acid and Iron Supplement Treatment Improves Stem Cell-Mediated Cartilage Regeneration in a Minipig Model.

Authors:  Ashok Joseph Theruvath; Elhussein Elbadry Mahmoud; Wei Wu; Hossein Nejadnik; Louise Kiru; Tie Liang; Stephen Felt; Heike Elisabeth Daldrup-Link
Journal:  Am J Sports Med       Date:  2021-04-19       Impact factor: 6.202

3.  Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.

Authors:  Nicole C McCoy; Ellen L Hay; Deborah A Romeo; J Wesley Doty; Bethany J Wolf; Michelle P Hudspeth
Journal:  Front Med (Lausanne)       Date:  2022-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.